SONOMA PHARMACEUTICALS, INC. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-11.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2022-02-11
- SONOMA PHARMACEUTICALS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2021-12-31 was $0.00.
- SONOMA PHARMACEUTICALS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2021-09-30 was $0.00.
- SONOMA PHARMACEUTICALS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2020-12-31 was -$0.01, a 111.11% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2021 was $0.33, a 83.33% increase from fiscal 2020.
- SONOMA PHARMACEUTICALS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2020 was $0.18.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-Q · filed 2022-02-11 | $0.00 10-Q · filed 2022-02-11 | |||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | $0.33 10-K · filed 2021-07-14 | ||||
| 2020-12-31 | -$0.01 10-Q · filed 2022-02-11 | $0.45 10-Q · filed 2022-02-11 | |||
| 2020-09-30 | -$0.02 10-Q · filed 2021-11-15 | $0.48 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $0.52 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | $0.18 10-K · filed 2021-07-14 | ||||
| 2019-12-31 | $0.09 10-Q · filed 2021-02-16 | $0.18 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | $0.06 10-Q · filed 2020-11-20 | $0.10 10-Q · filed 2020-11-20 | |||
| 2019-06-30 | $0.03 10-Q/A · filed 2020-11-17 | $0.14 10-Q · filed 2020-08-14 | |||
| 2017-12-31 | $0.00 10-Q · filed 2018-02-14 | $0.00 10-Q · filed 2018-02-14 | |||
| 2016-12-31 | $3.66 10-Q · filed 2018-02-14 | $4.15 10-Q · filed 2018-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |